With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

top 1%
Get Vertical! Going from Idea to the Top 1% in Less Than 3 Years
February 17, 2026

Independent retail is operating in one of the most competitive environments in decades. According to the U.S. Bureau of Labor Statistics, roughly 20% of new businesses fail within their first year, and a whopping 50% don’t make it to year five. At the same time, consumers are increasingly choosing brands that offer community, authenticity,…

Read More
MarTech
How CMOs Must Respond as AI Redefines Marketing and MarTech Strategy
February 16, 2026

AI is shifting marketing from experimentation to operational integration. In this episode, Aby Varma speaks with Palmer Houchins, VP of Marketing at G2, about embedding AI into workflows, rethinking org design, and navigating rapid change across the MarTech landscape. From LLM copilots to agentic workflows, they unpack practical adoption lessons and the increasing importance of…

Read More
experiential learning
Flood the Zone: University of Virginia’s New Strategy to Scale Experiential Learning for Every Student
February 16, 2026

Experiential learning is having a bit of a reckoning moment in higher ed. For years, the default answer was “get an internship” or “do a co-op”—as if every student can pause life, relocate for a summer, and take on a high-stakes role that’s supposed to define their future. But students’ realities have changed: many…

Read More
free tools
The True Cost of Free Tools: When Free Platforms Own More of Your Network Than You Do
February 12, 2026

Nowadays, getting a project off the ground usually means moving fast. A quick map gets sketched. A file gets shared. A design gets reviewed in whatever tool is closest at hand. In the moment, it feels efficient — even smart. But in the telecommunications industry, as networks become more automated, location-aware, and powered by AI,…

Read More